Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesKORU Medical Systems, Inc.

KORU Medical Systems, Inc.

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
3.89 USD 0.73 ( 23.10%)
Last update at 2026-11-11T21:03:00Z
VOLUME
721022
Market Cap
145.15M

Momentum Score

…

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.30
Low
3.96
High
52 Week Price Range
3.09
Low
6.61
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Repro Med Systems Inc appears to be a small publicly listed company operating in the reproductive medical device and services sector based on limited public filings. Industry drivers such as growing use of assisted reproductive technologies and demographic trends may support long-term demand; the company could appeal to investors seeking niche fertility/medical-device exposure if it achieves commercial traction.
Principal risks are limited disclosure and low liquidity, regulatory and commercialization hurdles, product concentration and small scale that may require additional financing, and competition from larger device makers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
3.16
Dividend Yield
-
Revenue TTM
45.11M
Revenue Per Share
0.97
Gross Profit TTM
28.16M
Debt / Equity
0.21
ROE
-10.52%
Net Debt
-5.38M
ROCE
-13.08%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.62M -6.06M -9.77M -10.68M -6.36M
Net income -2.64M -6.07M -13.74M -8.66M -4.56M
Selling general administrative 23.38M 21.63M 20.37M 20.61M 17.86M
Gross profit 25.60M 21.33M 15.84M 15.37M 13.77M
Reconciled depreciation 0.81M 0.89M 0.87M 0.59M 0.46M
Ebit -2.62M -6.06M -10.27M -10.74M -7.00M
Ebitda -1.81M -5.29M -9.40M -10.15M -6.54M
Depreciation and amortization 0.81M 0.77M 0.87M 0.59M 0.46M
Non operating income net other - - - 0.11M 0.67M
Operating income -2.97M -6.45M -10.27M -10.78M -7.03M
Other operating expenses 44.10M 40.09M 38.79M 38.68M 30.52M
Interest expense - - - 0.15M 0.64M
Tax provision 0.02M 0.00M 3.97M -2.01M -1.80M
Interest income 0.29M 0.44M 0.56M 0.15M 0.01M
Net interest income 0.29M 0.44M 0.56M 0.15M 0.01M
Income tax expense 0.02M 0.00M 3.97M -2.01M -1.80M
Total revenue 41.13M 33.65M 28.52M 27.90M 23.49M
Total operating expenses 28.58M 27.78M 26.11M 26.15M 20.80M
Cost of revenue 15.52M 12.31M 12.68M 12.53M 9.72M
Total other income expense net 0.36M 0.38M 0.50M -0.04M 0.65M
Net income from continuing ops -2.64M -6.07M -13.74M -8.66M 4.56M
Net income applicable to common shares - - - -8.66M -4.56M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 28.20M 27.22M 28.46M 42.33M 41.29M
Intangible assets 0.68M 0.73M 0.75M 0.79M 0.81M
Other current assets 0.91M 0.75M 1.22M 1.46M 1.57M
Total liab 11.15M 10.40M 8.11M 11.01M 4.79M
Total stockholder equity 17.05M 16.81M 20.35M 31.33M 36.50M
Other current liab 5.39M 4.76M 2.69M -0.28M 2.87M
Common stock 0.50M 0.49M 0.49M 0.49M 0.48M
Capital stock 0.50M 0.49M 0.49M 0.49M 0.48M
Retained earnings -32.02M -29.38M -23.31M -9.57M -0.91M
Other assets - - - 4.07M 1.96M
Cash 8.87M 9.58M 11.48M 17.41M 25.33M
Total current liabilities 8.19M 7.20M 4.45M 6.96M 4.79M
Current deferred revenue - - - 3.97M 0.09M
Net debt -5.38M -5.59M -7.04M -12.48M -24.73M
Short term debt 0.54M 0.79M 0.79M 0.88M 0.60M
Short long term debt - 0.27M 0.31M 0.43M 0.51M
Short long term debt total 3.50M 3.99M 4.45M 4.93M 0.60M
Other stockholder equity 48.57M 45.70M 43.18M 40.41M 36.93M
Property plant equipment - - - 3.89M 1.20M
Total current assets 19.99M 19.13M 20.26M 29.80M 37.32M
Net tangible assets - - - 30.54M 35.69M
Net receivables 6.53M 6.00M 4.07M 4.53M 4.31M
Inventory 3.68M 2.80M 3.48M 6.40M 6.11M
Accounts payable 2.27M 1.65M 0.98M 2.39M 1.23M
Accumulated other comprehensive income 0.00M 0.00M 0.00M - -
Common stock total equity - - - 0.49M 0.48M
Retained earnings total equity - - - -9.57M -0.91M
Treasury stock - - - -3.84M -3.84M
Non currrent assets other 0.10M 0.10M 0.10M 0.10M 0.02M
Non current assets total 8.21M 8.09M 8.21M 12.53M 3.97M
Capital lease obligations 3.50M 3.72M 4.13M 4.49M 0.10M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -1.33M -0.81M -2.80M -0.37M
Change to liabilities - - - 1.89M 0.69M
Total cashflows from investing activities -0.95M -1.33M -0.81M -2.80M -0.37M
Net borrowings -0.38M -0.15M -0.22M -0.13M 0.51M
Total cash from financing activities -0.22M -0.25M -0.22M 0.28M 2.71M
Change to operating activities - - - 0.50M -1.51M
Net income -2.64M -6.07M -13.74M -8.66M -4.56M
Change in cash -0.71M -1.90M -5.93M -7.93M -1.98M
Begin period cash flow 9.58M 11.48M 17.41M 25.33M 27.32M
End period cash flow 8.87M 9.58M 11.48M 17.41M 25.33M
Total cash from operating activities 0.46M -0.32M -4.89M -5.40M -4.32M
Issuance of capital stock - - 0.00M 0.41M 2.20M
Depreciation 0.81M 0.89M 0.87M 0.59M 0.46M
Other cashflows from investing activities -0.02M -0.04M -0.03M -0.04M -0.37M
Change to inventory -0.87M 0.68M 2.92M -0.30M 0.72M
Change to account receivables -0.49M -1.68M 0.46M 0.03M -1.02M
Sale purchase of stock - -0.10M - 0.41M 0.00M
Other cashflows from financing activities -0.03M -0.04M -0.03M 0.78M 0.92M
Change to netincome - - - 1.05M 0.89M
Capital expenditures 0.93M 1.30M 0.81M 2.80M 0.38M
Change receivables - - - -0.22M 1.02M
Cash flows other operating - - - 0.24M 0.76M
Cash and cash equivalents changes - - - -7.93M -1.98M
Change in working capital -0.32M 1.97M 1.20M 1.40M -1.11M
Stock based compensation 2.71M 2.62M 2.77M 3.08M 2.71M
Other non cash items -0.10M 0.26M 0.04M 0.21M -0.00M
Free cash flow -0.47M -1.62M -5.71M -8.21M -4.69M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
KRMD
KORU Medical Systems, Inc.		 0.73
23.10%		 3.89 - 78.74 3.22 8.06 3.11 -17.15
ISRG
Intuitive Surgical Inc		 0.21
0.05%		 450.25 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -11.76
5.48%		 202.74 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -3.10
2.95%		 101.85 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 1.91
0.90%		 214.52 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

KORU Medical Systems, Inc.

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

100 Corporate Drive, Mahwah, NJ, United States, 07430

845 469 2042

https://www.korumedical.com

73

Name Title Year Born
Ms. Linda M. Tharby Pres, CEO & Director 1968
Mr. Tom Adams Interim Chief Financial Officer NA
Mr. Christopher Pazdan Sr. VP of Operations NA
Mr. Brian Case Chief Technology Officer NA
Mr. Rob Cannon VP of Sales NA
Mr. Josh Bennett VP of Strategy & Bus. Devel. NA
Ms. Linda M. Tharby President, CEO & Director 1968
Mr. Thomas Adams CFO, Secretary & Treasurer 1973
Mr. Brian Case Chief Technology Officer 1973
Mr. Kenneth Miller Chief Commercial Officer 1969

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…